cabozantinib shows efficacy against previously treated differentiated thyroid cancer
Published 3 years ago • 386 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
4:09
cosmic-311: cabozantinib versus placebo in patients with radioiodine-refractory differentiated t...
-
55:43
cabozantinib for radioiodine-refractory differentiated thyroid cancer with dr. sherman
-
0:48
clinical activity of cabozantinib in patients with rcc with brain metastases
-
0:53
carina: cabozantinib post first-line immune-oncology cpi-containing combination in arcc
-
2:59
tkis for treating medullary thyroid cancer
-
7:02
using cabozantinib to treat medullary thyroid cancer—expert video 4 of 5
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
20:02
management of differentiated thyroid carcinoma in the era of targeted therapy
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
0:52
next steps for cabozantinib plus durvalumab in gi cancer
-
3:56
phase ii trial of pembrolizumab & cabozantinib in patients with recurrent metastatic hnscc
-
1:11
dr. manisha shah on cabozantinib impact on tumor shrinkage in differentiated thyroid cancer
-
1:16
predictions for thyroid cancer in the next 10 years
-
9:03
sequencing therapies for differentiated thyroid cancer
-
2:19
final results from atlantis cabozantinib arm for urothelial carcinoma
-
2:41
dr. sherman comments on cabozantinib and vandetanib in medullary thyroid cancer
-
9:34
precision medicine in thyroid cancer: metastatic and anaplastic disease (part 5)
-
7:08
final analysis of the atlantis cabozantinib comparison
-
0:31
finding hope in cancer science